wisconsin Archives - Native Roots Hemp

What Are the Benefits of CBD?

More than 60 percent of CBD users were taking it for anxiety, according to a survey of 5,000 people. Does it help?

By Dawn MacKeen

The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, conducted by the Brightfield Group, a cannabis market research firm.Chronic pain, insomnia and depression follow behind. Kim Kardashian West, for example, turned to the product when “freaking out” over the birth of her fourth baby. The professional golfer Bubba Watson drifts off to sleep with it. And Martha Stewart’s French bulldog partakes, too.

What is CBD?

Cannabidiol, or CBD,is the lesser-known child of the cannabis sativaplant; its more famous sibling, tetrahydrocannabinol, or THC, is the active ingredient in pot that catapults users’ “high.” With roots in Central Asia, the plant is believed to have been first used medicinally — or for rituals — around 750 B.C., though there are other estimates too.

Cannabidiol and THC are just two of the plant’s more than 100 cannabinoids. THC is psychoactive, and CBD may or may not be, which is a matter of debate. THC can increase anxiety; it is not clear what effect CBD is having, if any, in reducing it. THC can lead to addiction and cravings; CBD is being studied to help those in recovery.

Cannabis containing 0.3 percent or less of THC is hemp. Although last year’s Farm Bill legalized hemp under federal law, it also preserved the Food and Drug Administration’s oversight of products derived from cannabis.

What are the claims?

CBD is advertised as providing relief for anxiety, depression and post-traumatic stress disorder. It is also marketed to promote sleep. Part of CBD’s popularity is that it purports to be “nonpsychoactive,” and that consumers can reap health benefits from the plant without the high (or the midnight pizza munchies).

Just as hemp seedlings are sprouting up across the United States, so is the marketing. From oils and nasal sprays to lollipops and suppositories, it seems no place is too sacred for CBD. “It’s the monster that has taken over the room,” Dr. Brad Ingram, an associate professor of pediatrics at the University of Mississippi Medical Center, said about all the wild uses for CBD now. He is leading a clinical trial into administering CBD to children and teenagers with drug-resistant epilepsy.

How mainstream media botched the vape lung story

David Bienenstock

In 1989, a mysterious figure known as Dr. Lunglife sent High Times a set of detailed instructions for transforming a handful of easily obtained equipment into a low cost vaporizer. He included a guide to making a highly potent cannabis concentrate that optimized the contraption’s effectiveness.

Soon thereafter, the magazine published a letter to the editor from K.O. of Clarksville, Mississippi:

Just thought I’d let you know I built one of Dr. Lunglife’s vaporizers. Tell the good doctor that it has worked well for me. Now if I can just get a really long extension cord for the Hash Bash in Ann Arbor.”

30 years of user data on vaping

Clearly, many cannabis enthusiasts must have started experimenting with vaporization around this same time.

Commercial products required a little more time to make it to market. The first Volcano vaporizer, made by Storz & Bickel, appeared in the US in 2003. The first pen-size vaporizers appeared around 2006. Cannabis vape pens hit the American scene starting around 2010.

That gives us—at the very least—a solid three decades of anecdotal user data to work with when evaluating any potential harms involved.

So when a rash of people started getting seriously or even fatally ill after using vape pens earlier this year, it was obvious that something other than cannabis must be the culprit. The overwhelming number of cases of VAPI, vaping associated pulmonary injury, have been attributed to counterfeit products produced and distributed illegally without any regulatory oversight whatsoever.

Tainted illegal THC pens are suspect

At Leafly, our reporting team tracked these dangerous counterfeit pens from production to sale. We found a supply chain operating wholly outside the law and with a blatant disregard for public health. Theories on what’s causing VAPI range from dangerous additives to poorly manufactured pens, or possibly some combination of the two. No evidence has emerged to show THC, CBD, or any other cannabinoid is to blame.

BIG Announcement

Dear Valued Clients, Colleagues and Friends,

I’m writing today to inform you of an important change in the structure of One Health WI. As of last Friday, my business partner and I have mutually agreed to part ways. As always, you can count on me to continue to deliver the highest quality products at the best prices, just with a new look and new name! I’m excited to introduce you to: Native Roots Hemp !

As our new company continues to grow, so will our brand with a new look and feel. In the coming weeks you’ll see our online and print presence update with the new logo and information.

Many of you know that I am originally from Algoma, WI and have been very excited to move my family “back to my roots” as we launched our CBD business. We’ve already helped thousands of people across the country to feel better through our quality products and we’re looking forward to having our company’s name and brand signify getting “back to our roots” as well !

As our team at Native Roots Hemp continues to work with my family in Brussels, WI, who are farmers in the hemp industry, as well as our other valued suppliers from the past, rest assured you will continue to receive the highest quality products in the country, as you have since September, 2018.

Thank you for trusting us. You are all like family to our team and we look forward to continuing to partner with you on your wellness journey!

Please join me at the Luxemburg Pharmacy today, August 28th, from 8-2 for FREE samples and to answer any questions you may have.

See you soon!

Warmest regards,

Stacy Deprey-Purper, CEO
Native Roots Hemp
www.NativeRootsHemp.com

CBD Skincare Interest is Rising Fast: What’s the Future of Cannabidiol for Skin Health Look Like?

Since cannabidiol (CBD) was reintroduced as having potential health benefits, the areas that it appears to excel in include pain relief, reduction in anxiousness and attaining a calmer self. The key property in making the previously mentioned benefits a possibility is CBD’s ability to rid inflammation.

As the industry continues to mature, more and more skincare solutions are being infused with CBD and other cannabis’ compounds. With this in mind, curiosity is surely enticed, as consumers now have to assess its true effectiveness.

In a recent post shared by CBD Snapshot, the overall potential of CBD has been explained with respect to skincare. Turns out, it does in fact make a positive difference, however, consumers have been warned to be cautious of their resources.

CBD’s Anti-Inflammatory Properties Creates a Win-win Situation Once Again!
The news outlet referenced a board-certified dermatologist, who argued for the use of CBD for skin health. According to Dr. Jeanette, CBD can be effective in both beauty and skin care because of the very same anti-inflammatory properties that initially helped it to secure a spotlight.

Here’s an extract as to why the latter is so:

“Cannabinoid receptors have been discovered in keratinocytes, or skin cells, and other parts of the skin such as the sebaceous glands, hair follicles, small nerves and immune cells. CBD works on them as part of the skin’s endocannabinoid system.”

Dr. Robert Dellavalle, University of Colorado School of Medicine’s dermatology professor and a co-author of the 2017 study, has noticed how quickly the CBD industry has been developing and is somewhat fearful of consumers’ belief that all skin conditions can be resolved with its use. However, he does not question its general potential, adding that, “I think there’s a lot of promise.”

CBD: What it is, how it affects the body and who it might help

CBD has exploded onto the market, leaving a lot of confused consumers in its wake. Get up to speed with this beginner’s guide.

BY: DANIELLE KOSECKI

This story discusses substances that are legal in some places but not in others. You shouldn’t do things that are illegal, and this story does not endorse illegal drug use.

If it seems like you’re seeing CBD products everywhere, that’s because you are. Thanks to the passage of the US Farm Bill in 2018, which legalized industrial hemp, and the legalization of medical and recreational cannabis at the state level, CBD products have exploded in availability and popularity over the last year.

Depending on where you live, you can find them at CVS, your local gas station, pet stores — even Carl’s Jr. And the industry shows no signs of slowing down: Sales of CBD products are expected to exceed $5 billion this year, a 706% increase over 2018, according to the Brightfield Group, a cannabis-focused research firm.

The only thing spreading faster than CBD appears to be confusion over what exactly it is and who it’s for. Whether you’re already a user or are just CBD curious, this primer will help you cut through the misinformation and get up to speed.

What is CBD?
CBD, or cannabidiol, is a chemical compound from the cannabinoid family that naturally occurs in the cannabis plant. Scientists have isolated 108 different types of cannabinoids in cannabis.

Delta-9-tetrahydrocannabinol, or THC, is probably the best-known thanks to its psychoactive properties — it’s the one that gets you “high” — but CBD is quickly gaining ground due to its potential therapeutic benefits.

How does CBD work?
CBD (and THC) work by interacting with our body’s endocannabinoid system, a regulatory system made up of naturally occurring cannabis-like molecules. These endocannabinoids, as they’re called, work like neurotransmitters, shuttling messages through the body to help maintain homeostasis. Cannabinoids like CBD and THC interact with the endocannabinoid system at two known receptors: CB1 and CB2.

CBD as a Superbug Antibiotic?

June 24, 2019 — Cannabidiol, or CBD, already being researched and used for anxiety, insomnia, epilepsy and pain, may be the next superbug fighter for resistant infections, a new study suggests.

The researchers tested CBD against a wide variety of bacteria, ”including bacteria that have become resistant to the most commonly used antibiotics,” says Mark Blaskovich, PhD, senior research officer at the Centre for Superbug Solutions at the Institute for Molecular Bioscience at the University of Queensland in Australia.

The development is important, as antibiotic resistance is reaching dangerously high levels, according to the World Health Organization.

What the Research Shows

CBD is a non-psychoactive compound taken from cannabis and hemp; it does not produce the high that regular marijuana does. To date, the FDA has only approved CBD for treating rare and severe forms of seizure, although it is promoted for many other health benefits.

Blaskovich presented the research Sunday at the American Society for Microbiology annual meeting. The research includes work in test tubes and animal models. Research presented at meetings should be viewed as preliminary until published in a peer-reviewed medical journal.

“The first thing we looked at is CBD’s ability to kill bacteria,” he says. “In every case, CBD had a very similar potency to that of common antibiotics.”

The researchers tested the CBD against some strains of staphylococcus,which cause skin infections, and streptococcus, which cause strep throat.

They compared how effective CBD was compared to common antibiotics, such as vancomycin and daptomycin. “We looked at how quickly the CBD killed the bacteria. It’s quite fast, within 3 hours, which is pretty good. Vancomycin (Vancocin) kills over 6 to 8 hours.”

The CBD also disrupted the biofilm, the layer of ”goop” around bacteria that makes it more difficult for the antibiotic to penetrate and kill.

Finally, the lab studies showed that “CBD is much less likely to cause resistance than the existing antibiotics,” Blaskovich says.

The CBD ”is selective for the type of bacteria,” he says.

He found it effective against gram-positive bacteria but not gram-negative. Gram-positive bacteria cause serious skin infections and pneumonia, among other conditions. Gram-negative bacteria include salmonella (found in undercooked foods) and E. coli (the cause of urinary tract infections, diarrhea, and other ailments), among other bacteria.

In another study, also presented at the meeting, the researchers tested topical CBD to treat a skin infection on mice. It cut the number of bacteria after 48 hours, Blaskovich says, although it did not clear the infection. That research is ongoing.